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Background: Data collected by the Japanese Ministry of Health, Labour and Welfare (MHLW), namely data from the
Specific Health Checkups and Specific Health Guidance (MHLW-SH) and the National Health and Nutrition Survey
(MHLW-H&N) allow assessment of blood pressure (BP), low-density lipoprotein cholesterol (LDL-C), and hemoglobin
A1c (HbA1c) in Japan. Recently, a large database of employment-based health insurance has been developed by
MinaCare Co. Ltd.
Methods: A retrospective, cross-sectional study using the Japanese healthcare checkup database developed by
MinaCare Co. Ltd. was designed to investigate the distribution of real-world values of BP, LDL-C, and HbA1c in
Japan. Data in the MinaCare database were also compared with those in the two national data sources to assess
the extent to which the health status in Japan is reflected in each data source.
Results: Of the healthcare checkup results of 232515 subjects in the 2011 MinaCare database, 49.9% were male and
50.1% were female. The age of the subjects ranged from <20 to >70 years. The proportion of subjects with systolic
BP (SBP) ≥140 mmHg, LDL-C ≥140 mg/dL, and HbA1c ≥6.1% generally increased with increasing age. If one focused
on the upper-end age group representing the majority of the MinaCare study population (i.e. age range, 55–59
years), the proportions of subjects with SBP ≥140 mmHg, LDL–C ≥140 mg/dL, and HbA1c ≥6.1% were 19.0%/12.2%
(males/females), 27.2%/42.7%, and 13.5%/5.4%, respectively. The MinaCare database was mostly comparable with the
two national data sources; however, some notable differences in BP and lipid parameters were found between
MHLW-H&N and the other two data sources.
Conclusions: Analysis of the MinaCare database indicated that a substantial proportion of subjects did not achieve
the target BP, LDL-C, and HbA1c levels to reduce the risk of future cardiovascular and cerebrovascular disease events.
The results were generally consistent with those of the national data sources. Considering its characteristics of low
selection bias, large sample size, wide age distribution, and high flexibility in analysis of subject-level data, the
MinaCare database is highly valuable for studying the health status of the population covered by employment-based
health insurance.
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Cardiovascular and cerebrovascular diseases (CVDs) are
the second and third leading causes of death in Japan,
and it is well recognized that hypertension (HT), hyper-
lipidemia, and diabetes mellitus are the major risk fac-
tors for CVDs on a global basis [1,2]. The status of HT,
hyperlipidemia, and diabetes mellitus is monitored by
measuring blood pressure (BP), low-density lipoprotein
cholesterol (LDL-C), and hemoglobin A1c (HbA1c) levels,
respectively, which also indicate the future probability of
CVDs [1-3]. Therefore, academic societies provide target
values for these parameters to achieve better manage-
ment and prevention of these diseases worldwide. Such
target values are also provided by Japanese Society of
Hypertension (JSH) [4], the Japan Atherosclerosis Society
(JAS) [5], and the Japan Diabetes Society (JDS) [6] for
Japanese populations.
To monitor the actual health status of Japanese resi-
dents and to promote their health, the Japanese Ministry
of Health, Labour and Welfare (MHLW) regularly con-
ducts the National Health and Nutrition Survey (MHLW-
H&N) [7] and Specific Health Checkups and Specific
Health Guidance (MHLW-SH) [8,9].
MHLW-H&N has been conducted annually since 1947
to monitor and obtain basic information on health,
nutrition, and life style to further enhance measures to
improve the overall health of Japanese residents [7]. Data
is collected from Japanese residents of 1 year and older
who are randomly selected from each of approximately
2000 geographical sampling units and agree to partici-
pate in the survey. This data source has a relatively small
sample size (6914 subjects in 2011).
MHLW-SH was initiated in 2008 under the Japanese
health insurance system [8,9]. The health insurance sys-
tem has provided universal coverage and nation-wide
cost sharing since 1961. By law, insurers must offer their
subscribers aged 40–74 years an annual health checkup
that includes blood chemistry, urinalysis, and BP meas-
urement. A total of 22232094 subjects underwent the
annual checkup in 2010. The sample size of MHLW-SH
data is thus much larger than that of MHLW-H&N data,
but it does not contain data of individuals aged <40 years.
The individuals included in the MHLW-SH data source
also represent less than half of the total targeted popula-
tion (42.6% in 2010) because annual checkups are volun-
tary and rely on individuals’ voluntary participation. This
could cause significant selection bias.
These survey results are open to the public, and the
health status of the Japanese population is often esti-
mated based on these results. However, because access
to the subject-level data from these data sources is limited,
researchers often cannot conduct analyses that would
answer original research questions. Taking into consider-
ation the limitations of these two data sources, such as theselection bias of patients, limited number of patients, lim-
ited age distribution, and limited access to subject-level
data [10], we believe that an alternative and/or supple-
mental database is necessary to investigate and understand
the actual health status of this population.
Since 2011, a large database containing the results of
employment-based health insurance healthcare checkups
has been developed by MinaCare Co. Ltd (Tokyo, Japan).
The present study was conducted to better understand
the health status of working individuals and their code-
pendents in Japan by analyzing BP, LDL-c, and HbA1c
data included in the MinaCare database. To investigate
real-world values from various perspectives and to assess
the extent to which the actual health status in Japan is
reflected in each data source, the analysis results of data
from the MinaCare database were compared with those
from the publicly available summaries of MHLW-SH
and MHLW-H&N data. The usefulness of the MinaCare
database was also discussed.
Methods
Study design
This was a retrospective, cross-sectional study using a
commercially available Japanese healthcare database
(MinaCare Co. Ltd., Tokyo, Japan). The main aim of the
study was to examine BP, LDL-c and HbA1c values from
health checkup data from a cross-sectional viewpoint,
where a single time point for each individual was se-
lected for analysis. Smoking status, body mass index
(BMI), and waist circumference were also evaluated, be-
cause these three measures are also known risk factors
for CVDs. MinaCare data were then compared with the
latest (at the time of analysis) publicly available summary
results from MHLW-SH (2010) [8] and MHLW-H&N
(2011) [7].
MinaCare database
MinaCare Co. Ltd. manages healthcare data provided by
employment-based health insurance and offers health
risk reduction plans to corporate employees diagnosed
with obesity or those who have a high risk for any
lifestyle-related diseases. The MinaCare database in-
cludes regularly updated data of checkups and medical
and pharmaceutical claims since 2010 (Figure 1). The
population covered by the database includes working indi-
viduals and their dependent family members, and the
database covers a wide range of age groups. Employment-
based insurance covers large-scale, nation-wide retailers,
manufacturers, and those in food, information, transpor-
tation and energy industries. Therefore, the MinaCare
database includes health information of individuals with
minimal geographic or occupational bias, but it has
the limitation that individuals in the primary industries
such as agriculture, fishery and forestry, and those who are
Figure 1 Schematic description of the MinaCare database. The MinaCare database consists of checkup and claim data provided by
employment-based health insurance in Japan since 2010.
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include information on subjects’ demographics, smok-
ing status, vital signs, clinical laboratory test data, and
administrative information. Data of medical and pharma-
ceutical claims from approximately 1.1 million subjects
that are 3%-4% of the total insured individuals in Japan,
and health checkup data from approximately 338000 sub-
jects were collected into the MinaCare database as of
November 2013. Considering the nature of MinaCare
Co. Ltd, which manages healthcare data provided by
employment-based health insurance, and the fact that in-
surers must offer subscribers an annual health checkup, it
seems obvious that a high percentage of the target popula-
tion undergoes annual checkups.
Anonymization of subjects
This study used subject-level electronic health related
databases that protected the identity of individuals.
MinaCare is allowed to use such anonymized data under
the data transfer contract with its client health insurers.
We referred the “Ethical Guidelines for Epidemiological
Research” laid down by the Japanese Government [11],
although this study is outside the scope because the data
is protected by anonymization.
Data extraction and management of irregular data
All health checkup data included in the MinaCare data-
base for the fiscal years from 2010 to 2012 were
extracted. Health checkup examinations are normally
conducted annually, thus this dataset included subjects
with examination years that ranged from 1 up to a max-
imum of 3 years. In this study, all subjects who had at
least one set of health checkup data for the fiscal year2011 were selected (a total of 232515 subjects). For a
few subjects who underwent multiple examinations in
the same year, earliest examination data were used. It
was noted that 2011 was a representative cross-sectional
year for the range of fiscal years from 2010 to 2012 and
was also a single year that was most comparable with
the timing of the two national surveys.
Missing values were not imputed and were excluded
from analysis, unless otherwise noted. Non-numeric or
impossible values for numeric variables were handled as
missing values and were also excluded from the sum-
mary. The proportion and pattern of missing values were
monitored to consider any implications in the interpret-
ation of the results.
Study variables
General information (subject ID, year of examination,
birth year/month, and date of examination), sex, body
size measurements (height, weight, waist circumference,
BMI, obesity score), smoking status, vital signs (average
BP), and clinical laboratory tests [fasting blood glucose
(FBG), HbA1c, urine sugar, uric protein, total choles-
terol, triglyceride (TG), high density lipoprotein choles-
terol (HDL-c), and LDL-c] data were extracted from the
database. In addition, the age at the time of examination
was computed from the birth year/month by imputing
the first day of the month for the birth date. Smoking
status was based on a subject questionnaire regarding
the subject’s current smoking status.
In terms of HbA1c values, the values of the Japan
Diabetes Society (JDS) were used in Japan in 2011
for health checkups. HbA1c (JDS) ≥6.1%, comparable
with HbA1c [National glycohemoglobin standardization
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diabetes mellitus based on the JDS guideline [6,12].
Study endpoints
The primary endpoints of this study were the distribu-
tion of demographic variables, the distribution of BP
[systolic BP (SBP) and diastolic BP (DBP)], LDL-c, and
HbA1c values, and the proportion of subjects who
achieved the predefined BP, LDL-c, and HbA1c cutoff
levels. These endpoints were examined in various sub-
groups of interest.
The secondary endpoints of this study included the
distributions of HDL-c, TG and FBG values and the pro-
portion of subjects who achieved the respective predefined
cutoff levels and the proportion of subjects within each
cardiovascular and cerebrovascular risk level. These end-
points were examined in various subgroups of interest.
Cutoff levels for BP (SBP and DBP), lipid parameters
(LDL-c, HDL-c, and TG), HbA1c and FBG were based
on the JSH 2009 guideline [4], JAS 2012 guideline [5]
and JDS 2013 guideline [6], respectively.
Age (at examination), sex, height, weight, BMI, waist
circumference, and smoking status were considered as
covariates. Subgroups defined by the levels of the covari-
ates were examined.
Statistical method
This analysis was primarily based on descriptive statis-
tical methods, and formal statistical inference was notFigure 2 Age distributions in the MinaCare, MHLW-SH, and MHLW-H&used. For continuous data, summary statistics such as
mean, median, minimum, maximum, and standard de-
viation (SD) were used. For binary and categorical
data, summary statistics such as numbers and propor-
tions (percentages) were used. Graphical presentations
were used to describe data. To enhance visual com-
parisons, graphical presentations of means and pro-
portions of various endpoints were made without
standard errors or confidence intervals. Because the
number of subjects (n) in each sex and age category
was generally very large (as seen in Figures 2 and 3),
this simplification did not affect the appropriate inter-
pretation of data. However, special notes on variability
were made when indicated.
The Structured Query Language was used to extract
data from the MinaCare database. SAS version 9.2
was used to derive datasets for statistical analyses. R
(version 2.15.2) and MS EXCEL 2007 were used to
create graphs.
Existing data sources used for the comparison with
MinaCare database
The summary level results of MHLW-SH data (2010)
and MHLW-H&N data (2011) were obtained from exist-
ing reports open to the public on the MHLW homepage
[7,8]. The number of reported subjects (sex tabulation)
was 22232094 (12228976 males and 10003118 females)
in MHLW-SH data (2010) and 6914 (3159 males and
3755 females) in MHLW-H&N data (2011).N data.
Figure 3 Age distributions in the MinaCare and MHLW-SH data. The age distributions of subjects ≥40 years are shown and the MHLW-SH
data are classified by employment-based health insurance.
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Subjects were classified according to their BP levels
based on the JSH 2009 guideline [4]. In this guideline,
the following six categories were defined based on com-
bination of SBP and DBP values: ideal, normal, normal
(high), HT class I, HT class II, and HT class III.
Results
MinaCare database
Overall characteristics of the study population
The characteristics of the study population by sex are
shown in Table 1.
Of 232515 subjects, 49.9% were male and 50.1% were
female. The age of subjects ranged from <20 to >70 years
(Table 1 and Figure 2). The greatest proportion of the
population was in their 40’s in both males (38.6%) and
females (50.1%) (Table 1); the proportion in their 40s
was nearly 10% higher in female subjects, as shown in
Figure 2. Nearly 90% were <60 years in both males
and females. When the proportion of subjects with
BMI ≥25 kg/m2 was plotted against age, the peak age
was 40–49 years in males, whereas the proportion
gradually increased and plateaued at 60 years or older in
females (Figure 4A). Similar trends were seen for the
mean BMI values (data not shown). The proportion of
subjects with a waist circumference above the cut-off
values (85 cm in males and 90 cm in females) gradually
increased and plateaued at 60 years or older in males,whereas a steady increase across the entire age range was
seen in females (Figure 4B). The proportion of current
smokers among males was approximately twice the pro-
portion among females (Figure 5). We noted that age
groups were confounded by birth-year cohorts, and any
description of “trends with increasing age” in this paper
should be interpreted keeping this in mind.
BP (SBP and DBP), lipid parameters (LDL-c, HDL-c, and TG),
HbA1c and FBG levels
Summary statistics of BP, lipid parameters, HbA1c, and
FBG values are presented in Table 2.
As shown in Figure 6A, the proportion of subjects
with SBP ≥140 mmHg increased with increasing age
both in male and female subjects. A similar trend was
seen for the mean SBP values (data not shown). The
proportion of subjects with DBP ≥90 mmHg is shown in
Figure 6B. In contrast with SBP, the proportion of male
subjects with DBP ≥90 mmHg peaked at mid-50s with a
value of nearly 20% and declined thereafter. This peak
was less pronounced in females, and the proportion
seemed to plateau at 60 years or older; the proportion
was smaller in females than in males across all age
groups. The proportion of subjects in each BP classifica-
tion category based on the JSH 2009 guideline is shown
for each age category in Figure 7 and Table 3. The ma-
jority of subjects were classified as “ideal” or “normal”
for both sexes in all age groups, and the proportion
Table 1 Characteristics of the study population in the
MinaCare database
Male Female
N = 115928 N = 116587
Sample size (Total: 232515) 115928 116587
Age (years)
n (%) [n missing] 115928 (100) [0] 116587 (100) [0]
−19 647 (0.6) 173 (0.1)
20-29 5730 (4.9) 3020 (2.6)
30-39 24408 (21.1) 11512 (9.9)
40-49 44801 (38.6) 58456 (50.1)
50-59 27691 (23.9) 28676 (24.6)
60-69 11424 (9.9) 13217 (11.3)
70- 1227 (1.1) 1533 (1.3)
Height (cm)
n [n missing] 115864 [64] 116490 [97]
mean (SD) 170.9 (5.89) 157.8 (5.51)
Weight (kg)
n [n missing] 115855 [73] 116480 [107]
mean (SD) 69.6 (10.88) 54.4 (9.14)
BMI (kg/m2)
n [n missing] 115851 [77] 116475 [112]
mean (SD) 23.8 (3.37) 21.8 (3.54)
Waist Circumference (cm)
n [n missing] 114777 [1151] 114486 [2101]
mean (SD) 83.9 (9.02) 77.9 (9.51)
Smoking Status n (%)
n [n missing] 115105 (100) [823] 115661 (100) [926]
Yes 38425 (33.4) 17616 (15.2)
No 76680 (66.6) 98045 (84.8)
n: number of subjects with available data; n missing: number of subjects with
missing data; SD: standard deviation: BMI: body mass index.
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The proportion shifted toward hypertensive classifica-
tions with increasing age in both sexes.
The proportion of subjects with LDL-c ≥140 mg/dL,
HDL-c <40 mg/dL, and TG ≥150 mg/dL are shown in
Figures 8A, B, and C, respectively. For LDL-c, male and
female subjects showed different patterns for the propor-
tion. In males, the proportion peaked at around 50 years
with a value of 30%; but in females, it peaked at a
higher age group with higher peak values (above 40%).
The proportion was lower in females than in males
aged <50 years, but was reversed (higher in females) in
higher age groups. The trend was similar for the mean
LDL-C values (data not shown). The proportion of fe-
males with HDL-c <40 mg/dL was lower than that of
males in all age groups; the difference between both sexesincreased and peaked around 40 years and narrowed very
slightly in higher age groups. A similar trend in the dif-
ference between sexes was seen for the mean HDL-c
values, which were generally 5–10 mg/dL higher in female
subjects (data not shown). The proportion of subjects with
TG ≥ 150 mg/dL reached a peak of approximately 30% at
50 years in males, whereas the proportion increased to
60 years and then plateaued in females. The proportions
in males were higher across all age groups. A similar trend
was seen for the mean TG values (data not shown).
Finally, the proportion of subjects with HbA1c ≥ 6.1%
showed a generally monotonic increase with increasing
age in both male and female subjects, with generally
higher values in males. The proportions reached a plateau
at a lower age group in males (around 60 years) compared
with females. The mean HbA1c values showed similar
trends (data not shown). It was noted that the database
contained a substantial proportion of missing values for
HbA1c (approximately 30% in males and 15% in females).
This may have an impact on the interpretation of the re-
sults if the missing values did not occur at random (e.g.
lower values are more likely to be missing). Similar age
trends as those for HbA1c were seen for FBG values.
Comparison with the MHLW-SH and MHLW-H&N
data sources
Demographics and age distributions
A notable difference was found in the age distribution of
male and female subjects among the data sources. The
proportion of subjects aged 40–49 years was higher in
females than in males in MinaCare data, whereas the
proportion was similar between the sexes (MHLW-
H&N) or slightly higher in males (MHLW-SH) in the
other two data sources. The MinaCare database included
data of subjects <40 years, while the MHLW-SH data
source did not (Figure 2). Age distribution in the MHLW-
H&N data source was more evenly spread in subjects aged
from <19 to >70 years compared with the other two data
sources, due to its sampling design.
In MHLW-SH data, age distributions for each of the
six types of health insurance schemes were available
(Figure 3). When we limited subjects to those aged
40 years or older in MinaCare data, age distributions in
MinaCare data were most similar to those in employment-
based health insurance in MHLW-SH data (see G4
“Union” in Figure 3).
BMI and waist circumference
Trends in the proportions of subjects with BMI ≥25 kg/m2
with increasing age were similar among the three data
sources. In males, the proportion rapidly increased with in-
creasing age up to 40 years, and the highest proportion
was found among subjects aged 40–49 years. In females,
the proportion gradually increased with increasing age.
AB
Figure 4 Distributions of BMI and waist circumference in the MinaCare, MHLW-SH, and MHLW-H&N data. A: Proportions of subjects with
BMI ≥25 (kg/m2). B: Proportions of subjects with waist circumference >85 cm (male) / >90 cm (female). Squares represent males and circles
represent females. Black, grey, and open symbols represent the MinaCare, MHLW-SH, and MHLW-H&N data, respectively. Interpretation of the
results for subjects aged ≥75 years requires care due to the small sample size (11 males and 6 females) in the MinaCare data.
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ally higher across all age groups compared with that in
MinaCare and MHLW-SH data (Figure 4A). The mean
BMI values showed trends similar to those for proportions
(data not shown).
The proportion of subjects with a waist circumfer-
ence ≥85 cm in males and ≥90 cm in females was slightly
higher across all age groups in MHLW-H&N data com-
pared with MinaCare and MHLW-SH data (Figure 4B).
BP
The BP value was the average of the parameters from
two BP measurements, and the same protocol was
adopted across the three data sources.In all data sources, the proportion of subjects with
SBP ≥140 mmHg increased with increasing age (Figure 6A);
however, the proportions in the MHLW-H&N data source
diverged from those in the other two data sources in higher
age groups. Across the age range, the proportions were the
smallest in MinaCare data, closely followed by the propor-
tions in MHLW-SH data. The highest proportions
were found in MHLW-H&N data, and >50% reported
SBP ≥140 mmHg in the highest age group for both sexes.
In MinaCare data, the proportions remained at values
below 30% in all age groups for both sexes. Similar trends
were found for the mean SBP values (data not shown).
Similar to SBP, the proportions of DBP ≥90 mmHg
were the smallest both in males and females in MinaCare
Figure 5 Proportion of current smokers among males and females by age in the MinaCare data.
Table 2 BP, lipid parameters, HbA1c and FBG levels in
the study population in the MinaCare database
Male Female
N = 115928 N = 116587
SBP (mmHg)
n [n missing] 115590 [338] 116363 [224]
mean (SD) 121.8 (15.25) 114.4 (16.54)
DBP (mmHg)
n [n missing] 115586 [342] 116360 [227]
mean (SD) 77.1 (11.29) 70.3 (11.22)
LDL-c (mg/dL)
n [n missing] 115188 [740] 114378 [2209]
median (1st; 3rd quartiles) 120 (101; 141) 116 (96; 138)
HDL-c (mg/dL)
n [n missing] 115228 [700] 114460 [2127]
median (1st; 3rd quartiles) 55 (47; 65) 69 (59; 79)
TG (mg/mL)
n [n missing] 115222 [706] 114454 [2133]
median (1st; 3rd quartiles) 105 (74; 155) 72 (53; 101)
HbA1c (% [JDS])
n [n missing] 79663 [36265] 98308 [18279]
median (1st; 3rd quartiles) 5.0 (4.8; 5.3) 5.0 (4.8; 5.2)
FBG (mg/dL)
n [n missing] 112350 [3578] 105129 [11458]
median (1st; 3rd quartiles) 93 (87; 100) 89 (84; 95)
n: number of subjects with available data; n missing: number of subjects with
missing data; SD: standard deviation; SBP/DBP: systolic/diastolic blood pressure;
LDL-c/HDL-c: low/high density lipoprotein cholesterol; TG: triglyceride; HbA1c:
hemoglobin A1c; JDS: Japan Diabetes Society; FBG: free blood glucose.
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(Figure 6B). Notably higher proportions were seen
across all age groups for both sexes in the MHLW-
H&N data source compared with the other two data
sources.Lipid parameters
The proportion of subjects with LDL-c ≥140 mg/dL in
MinaCare and MHLW-SH data was similar across the
age groups (Figure 8A). Although the pattern of change
with increasing age was similar to that in the other two
data sources, the proportions were lower across all age
groups in the MHLW-H&N data source when com-
pared with the other two data sources. More than 30%
of females had LDL-c ≥140 mg/dL in the age group of
60–69 years in all data sources. A similar trend was
found for the mean LDL-c values (data not shown).
The proportion of subjects with HDL-c <40 mg/dL
was higher in the MHLW-H&N data source than in the
other two data sources, particularly in male subjects
(Figure 8B). The proportions increased with increasing
age in subjects 60 years or older in all the three data
sources, except for male subjects in MinaCare data who
showed a slight decline.
The proportion of subjects with TG ≥150 mg/dL
showed a similar trend for MinaCare and MHLW-SH
data (Figure 8C). Although the pattern of change with
increasing age was similar to that in the other two data
sources, the proportions were much higher across all
age groups in MHLW-H&N data source compared with
the other two data sources.
Figure 6 BP distributions in the MinaCare, MHLW-SH, and MHLW-H&N data. A: Proportions of subjects with SBP ≥140 mmHg. B: Proportions
of subjects with DBP ≥90 mmHg. Squares represent males and circles represent females. Black, grey, and open symbols represent the MinaCare,
MHLW-SH, and MHLW-H&N data, respectively. Interpretation of the results for subjects aged ≥75 years requires care due to the small sample size
(11 males and 6 females) in the MinaCare data.
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The proportion of male subjects with HbA1c ≥6.1%
showed a generally similar pattern among all the three
data sources (Figure 9). In MHLW-H&N data source,
the proportions were 5-6% higher than those in the other
two data sources in males aged 65–74 years. An apparent
small peak was seen at 50–54 years in MinaCare data,
but a similar peak was not seen for the mean HbA1c
values (data not shown). The proportion of male subjects
with HbA1c ≥6.1% was high (33.3%) in females 75 years
or older; however, the sample size of subjects was small
(6 subjects). The mean HbA1c values were generally
similar among the three data sources (data not shown).Discussion
In this study, BP, lipid parameters, and blood glucose
levels in Japanese residents were investigated using the
MinaCare database. Data in the MinaCare database were
also compared with those in the two national data
sources: MHLW-SH and MHLW-H&N. The results of
age trends by sex for the parameters analyzed in this
study were generally consistent across the three data
sources evaluated in this study. The results of most of the
parameters analyzed in this study were also consistent with
those reported in previous studies in Japan [13-15].
This Japanese study showed that target BP, LDL-c and
HbA1c levels were not achieved in a substantial number
Figure 7 Proportions of subjects in each BP classification category (JSH 2009). A: Male. B: Female. Interpretation of the results for subjects
aged ≥75 years requires care due to the small sample size (11 males and 6 females) in the MinaCare data.
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(SBP) of ≥140 mmHg, LDL-C levels of ≥140 mg/dL, and
HbA1c levels of ≥6.1% generally increased with increas-
ing age. For example, if one focused on the upper-end
age group representing the majority of the MinaCare
study population (i.e. age range, 55–59 years), the pro-
portions of subjects with SBP of ≥140 mmHg, LDL–C
levels of ≥140 mg/dL, and HbA1c levels of ≥6.1% were
19.0%/12.2% (males/females), 27.2%/ 42.7%, and 13.5%/
5.4%, respectively.
As per the World Health Organization (WHO) re-
ports, the prevalence of CVDs has increased worldwide
over time, and increased BP, cholesterol and blood sugar
levels have been found to be significant health care issue
on a global base [16]. According to the WHO’s Worldmap showing the global distribution of the burden of
CVDs, Japan is categorized as a country of with a less
CVD burden, and it is considered that the Japanese pop-
ulations has relatively good values for BP, LDL-c, and
HbA1c levels [16]. As a result, the average life-span of
the Japanese population is the longest in the world. In
fact, Japan has a well-established health care system and
provides free and equal access to health care service to
all citizens. This study provides a critical message that
even in a country such as Japan with a highly acclaimed
health care system, target BP, LDL-C, and HbA1c levels
are not achieved in a substantial number of subjects and
that CV risks in the population need to be improved.
Considering the currently available wide range of pharma-
cological intervention for HT, hyperlipidemia, and diabetes
Table 3 Proportions (%) of subjects in each BP classification category (JSH 2009)
Sex Age
BP classification category
Ideal Normal Normal (high) HT class I HT class II HT class III
Male
<20 55.4 32.5 9.1 2.9 n/a n/a
20- < 25 53.8 33.7 9.2 3.0 0.3 n/a
25- < 30 49.8 34.6 10.3 4.8 0.5 0.0
30- < 35 47.6 33.1 10.9 6.8 1.4 0.2
35- < 40 51.7 27.3 12.0 6.8 1.7 0.5
40- < 45 45.7 26.8 13.8 10.2 2.7 0.8
45- < 50 40.3 25.7 15.3 13.8 3.8 1.0
50- < 55 32.4 25.8 18.2 17.8 4.7 1.0
55- < 60 29.0 25.4 19.6 20.1 5.0 0.9
60- < 65 28.4 24.4 21.3 19.6 5.6 0.8
65- < 70 27.7 23.5 23.0 20.9 3.9 0.9
70- < 75 28.0 22.3 23.8 21.0 4.4 0.5
75- 45.5 27.3 n/a 27.3 n/a n/a
Female
<20 83.2 14.5 1.2 1.2 n/a n/a
20- < 25 85.6 12.2 1.2 0.9 0.1 n/a
25- < 30 84.1 13.4 2.1 0.3 0.1 n/a
30- < 35 81.9 13.8 2.7 1.3 0.3 0.1
35- < 40 79.8 13.0 4.7 2.0 0.4 0.1
40- < 45 74.7 14.6 6.3 3.3 0.8 0.3
45- < 50 64.5 18.1 9.7 5.8 1.6 0.4
50- < 55 53.9 21.0 13.0 9.4 2.1 0.6
55- < 60 44.8 23.5 17.0 11.4 2.7 0.6
60- < 65 38.5 23.4 20.2 14.2 3.0 0.7
65- < 70 35.1 24.2 21.1 15.9 3.2 0.5
70- < 75 29.3 24.1 23.4 17.7 4.5 1.0
75- 33.3 n/a 66.7 n/a n/a n/a
JSH2009: The Japanese Society of Hypertension Guidelines for the Management of Hypertension, 2009; HT class: hypertension class; n/a: no subject in the
indicated category.
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http://www.biomedcentral.com/1471-2261/14/120mellitus, it is highly important to understand the real
world situation for enforcing such interventions to
achieve better control and reduce the future prevalence
of CVDs. In view of these findings, real world data
should be proactively introduced worldwide.
A detailed comparative review of these three data
sources was conducted in this study. With respect to
demographics and age distributions, the limitation of
the MHLW-SH data is that it only included subjects
aged 40–74 years; therefore, this data source is not
suitable to investigate the health conditions of individ-
uals aged <40 years. Age distribution of MHLW-H&N
data was evenly spread out due to the sampling design.
However, the number of subjects in this data source
was much smaller than that in the MinaCare database
for every age group, including the group of subjects
aged 70 years or older (Figure 2). Thus, the MinaCaredatabase has a strong advantage in terms of the sample
size and age distribution.
Regarding investigational items such as BMI, waist cir-
cumference, BP, LDL-c, HDL-C, and TG, the results of
the MHLW-H&N data source were different results
compared with those of the MHLW-SH and MinaCare
data sources, and the latter two data sources generally
showed similar results. the results of the MHLW-SH
data source, which included individuals from all over
Japan with a broad range of occupations, were similar to
those of the MinaCare data source. Thus, the difference
in the results between MHLW-H&N and the MHLW-
SH/MinaCare data sources is not explained by the char-
acteristics of the population in either MinaCare or
MHLW-SH data.
The unique tendency of the results shown by in the
MHLW-H&N data source seems to be related to the
AB
C
Figure 8 (See legend on next page.)
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Figure 8 Lipid parameter distributions in the MinaCare, MHLW-SH, and MHLW-H&N data. A: Proportions of subjects with LDL-c ≥140 mg/dL.
B: Proportions of subjects with HDL-c <40 mg/dL. C: Proportions of subjects with TG ≥150 mg/dL. Squares represent males and circles represent
females. Black, grey, and open symbols represent the MinaCare, MHLW-SH, and MHLW-H&N data, respectively. Interpretation of the result is for
subjects aged ≥75 years requires care due to the small sample size (11 males and 6 females) in the MinaCare data.
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http://www.biomedcentral.com/1471-2261/14/120distinctive characteristics of its population. Compared
with the other two data sources, the MHLW-H&N data
source included individuals who lived in selected areas
of every prefecture that had the smallest population. As
recently reported, the MHLW-H&N data showed signifi-
cant bias in the assessment of health status due to lim-
ited data, the methods used to identify target subjects,
and quality control issues [10,17]. Dissimilarities be-
tween data for BMI, waist circumference, BP, LDL-c,
HDL-c and TG in the MHLW-H&N data source and
data in the other two data sources could be caused by
these biases in the population included in these data
sources. Unfortunately, however, we could not further
investigate the background of the differences between
data in the MHLW-H&N data source and the other
two data sources. The reason for this is that access to
subject-level data from these national data sources is re-
stricted, which is another limitation of these two data
sources. The MinaCare database has high flexibility in
analysis of subject-level data, which is a strong advan-
tage for assessing the true meaning of individual values.
The MinaCare database consists of data from corpor-
ate employees and their dependents in private corporateFigure 9 Distributions of subjects with HbA1c ≥6.1% in the MinaCare
circles represent females. Black, grey, and open symbols represent the Mina
the result for subjects aged ≥75 years requires care due to the small samp
for females of ≥75 years in the MinaCare data is off-scale.health insurance societies. This means that their demo-
graphics and socioeconomic status may not represent
the overall Japanese population. Elderly subjects are par-
ticularly underrepresented in the MinaCare database.
Although there are such limitations of the MinaCare
database, we believe that the database is a proper reflec-
tion of the health status of the people insured by
employment-based health insurance, and that it is highly
valuable when studying that population.
In summary, the MinaCare database has several
strengths including low selection bias due to the high
screening rate for annual health checkups among the
target population, larger sample size compared with that
of MHLW-H&N, and wider age distribution compared
with that of MHLW-SH. One remarkable advantage of
the MinaCare database is that a longitudinal investiga-
tion can be conducted based on subject-level data, which
allows investigators to follow up health checkup data
from the same individual over time. Another notable ad-
vantage is that by combining health checkup data with
pharmaceutical claim data that are also available in the
database, disease prevalence, intervention outcomes, and
the efficacy and safety of treatments can also be studied., MHLW-SH, and MHLW-H&N data. Squares represent males and
Care, MHLW-SH, and MHLW-H&N data, respectively. Interpretation of
le size (11 males and 6 females) in the MinaCare data. * The proportion
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http://www.biomedcentral.com/1471-2261/14/120Such future studies using the MinaCare database will
provide important information to understand and im-
prove the health conditions of the insured population in
Japan. Concurrently, disease management processes and
methods that measure effects will be globally improved
by research on these databases.Conclusions
In this study, the distribution of real-world values of
BP, LDL-c, and HbA1c were fully described using the
MinaCare database. Analysis of MinaCare data indicated
that a substantial proportion of subjects did not achieve
target BP, LDL-c, and HbA1c levels to reduce the risk of
future CVD events even in Japan where health care ser-
vice is relatively well provided in the world. The results
were compared with those from the publicly available re-
ports of MHLW-SH and MHLW-H&N. Age trends by
sex for various parameters were generally consistent in
the three data sources evaluated in this study, although
some notable differences were observed.
Considering the characteristics of the MinaCare data-
base, such as low selection bias, large sample size, wide
age distribution, and high flexibility in analysis of
subject-level data, the database is highly valuable for
studying the health status of the individuals insured
by employment-based health insurance.
Abbreviations
BP: Blood pressure; BMI: Body mass index; CVD: Cardiovascular and
cerebrovascular disease; DBP: Diastolic blood pressure; FBG: Fasting blood
glucose; HbA1c: Hemoglobin A1c; HDL-c: High-density lipoprotein cholesterol;
HT: Hypertension; JDS: Japan diabetes society; JSH: Japanese society of
hypertension; LDL-c: Low-density lipoprotein cholesterol; MHLW: Ministry of
Health, Labour and Welfare; MHLW-H&N: MHLW national health and nutrition
survey; MHLW-SH: MHLW specific health checkups and specific health guidance;
n: Number of subjects; NGSP: National glycohemoglobin standardization
program; SBP: Systolic blood pressure; SD: Standard deviation; TG: Triglyceride.
Competing interests
Daisuke Shima, Yoichi Ii, Yumiko Ikeda and Yoko Fujimoto are full-time
employees of Pfizer Japan Inc. Yuji Yamamoto is the founder and CEO
of MinaCare Co. Ltd., and Satoshi Nagayasu is an employee of MinaCare
Co. Ltd.
Authors’ contributions
DS, YI (the statistician) and YF were involved in the conceptual development
and study design. YY and SN developed the database and YI (the statistician)
performed statistical analysis. All authors including YI (the medical writer)
participated in the interpretation of data, drafting and/or revising the manuscript
critically for important intellectual content. All authors gave their final approval to
the manuscript to be submitted.
Author details
1Medical Affairs, Pfizer Japan Inc., 3-22-7 Yoyogi, Shibuya-ku, Tokyo 151-8589,
Japan. 2Clinical Statistics, Pfizer Japan Inc., 3-22-7 Yoyogi, Shibuya-ku, Tokyo
151-8589, Japan. 3MinaCare Co. Ltd., Japan, 1-23 Kandanishiki-cho, Chiyoda-ku,
Tokyo 101-0054, Japan. 4Medical Writing, Pfizer Japan Inc., 3-22-7 Yoyogi,
Shibuya-ku, Tokyo 151-8589, Japan.
Received: 19 February 2014 Accepted: 9 September 2014
Published: 17 September 2014References
1. National Ministry of Health, Labour and Welfare Database. [http://www.e-stat.
go.jp/SG1/estat/NewList.do?tid=000001031167] (in Japanese).
2. WHO statistical information system on causes of death, mortality and
health status. http://www.who.int/research/en/.
3. Okamura T, Kadowaki T, Hayakawa T, Kita Y, Okayama A, Ueshima H,
Nippon Data80 Research Group: What cause of mortality can we
predict by cholesterol screening in the Japanese general population?
J Intern Med 2003, 253:169–180.
4. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, Imai Y,
Imaizumi T, Ito S, Iwao H, Kario K, Kawano Y, Kim-Mitsuyama S, Kimura G,
Matsubara H, Matsuura H, Naruse M, Saito I, Shimada K, Shimamoto K,
Suzuki H, Takishita S, Tanahashi N, Tsuchihashi T, Uchiyama M, Ueda S,
Ueshima H, Umemura S, Ishimitsu T, Rakugi H, et al: The Japanese Society
of hypertension guidelines for the management of hypertension (JSH 2009).
Hypertens Res 2009, 32:3–107.
5. The Japan Atherosclerosis Society: Japan Atherosclerosis Society (JAS)
Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases. Tokyo:
2012 (in Japanese).
6. The Japan Diabetes Society (JDS): Evidence-based Practice Guideline for
the Treatment of Diabetes in Japan. 2013. [http://www.jds.or.jp/modules/
en/index.php?content_id=44]
7. Data Source of the National Health and Nutrition Survey. [http://www.
mhlw.go.jp/bunya/kenkou/kenkou_eiyou_chousa.html] (in Japanese).
8. Data Source of the Specific Health Checkups and Specific Health
Guidance. [http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/
info02a-2.html] (in Japanese).
9. Specific Health Checkups and Specific Health Guidance. http://www.
mhlw.go.jp/english/wp/wp-hw3/dl/2-007.pdf.
10. Sasaki S: The value of the National Health and nutrition survey in Japan.
Lancet 2011, 378:1205–1206.
11. Ministry of Education, Culture, Sports, Science and Technology, Ministry of
Health, Labour and Welfare: Ethical Guidelines for Epidemiological
Research. 2008. [http://www.niph.go.jp/wadai/ekigakurinri/guidelines.pdf]
12. Kashiwagi A: Development of the HbA1c international standardization of
HbA1c measurement in Japan Diabetes Society. Rinsho Byori 2013,
61:585–593 (in Japanese).
13. Nguyen HN, Fujiyoshi A, Abbott RD, Miura K: Epidemiology of cardiovascular
risk factors in asian countries. Circ J 2013, 77:2851–2859.
14. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM,
Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M, Global Burden of
Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass
Index): National, regional, and global trends in body-mass index since 1980:
Systematic analysis of health examination surveys and epidemiological
studies with 960 country-years and 9.1 million participants. Lancet 2011,
377:557–567.
15. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK,
Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA,
Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases
Collaborating Group (Blood Glucose): National, regional, and global
trends in fasting plasma glucose and diabetes prevalence since
1980: Systematic analysis of health examination surveys and
epidemiological studies with 370 country-years and 2.7 million participants.
Lancet 2011, 378:31–40.
16. WHO: Global Atlas on cardiovascular disease prevention and control.
2013. http://whqlibdoc.who.int/publications/2011/9789241564373_eng.pdf.
17. Tokudome S, Nishi N, Tanaka H: Towards a better National Health and
Nutrition Survey in Japan. Lancet 2012, 379:e44.
doi:10.1186/1471-2261-14-120
Cite this article as: Shima et al.: A retrospective, cross-sectional study of
real-world values of cardiovascular risk factors using a healthcare database
in Japan. BMC Cardiovascular Disorders 2014 14:120.
